ICO.ST

Healthcare Medical Devices

Iconovo AB (publ)

SEK 1.25

-0.01 -1.19% today

Price History

Not enough data

Key Stats

Market Cap

120.21M

Avg Volume

58,410

EPS

-SEK 0.61

52W High

SEK 2.30

52W Low

SEK 0.87

Div. Yield

0.0%

Valuation

Forward P/E

-1.14

P/B Ratio

0.81

P/S Ratio

69.82

EV/EBITDA

-2.31

EV/Revenue

50.77

Margins

Gross Margin (197.5%)

Operating Margin (1737.9%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

322.0%

Return on Equity

(27.2%)

Return on Assets

(15.3%)

Liquidity & Leverage

Current Ratio

3.06

Quick Ratio

3.06

Debt / Equity

0.03

Total Cash

37.12M

Total Debt

4.32M

About

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreement with Lonza to develop spray-dried formulations of an intranasal biologic drug; and agreement with Kiox Pharma to develop an inhalable treatment for interstitial lung disease. The company was incorporated in 2013 and is headquartered in Lund, Sweden.